Associate editor: P. FosterInflammatory mechanisms and treatment of obstructive airway diseases with neutrophilic bronchitis
Introduction
Obstructive airway diseases such as asthma and chronic obstructive pulmonary disease (COPD) are major global health issues. Airway inflammation is a key element of both diseases and assessment of the pattern of granulocyte infiltration is a useful indicator of likely mechanisms as well as treatment responsiveness. Persistent neutrophilic airway inflammation (neutrophilic bronchitis; Fig. 1) occurs with innate immune activation and is considered a typical feature of COPD. However, a prominent neutrophilic bronchitis is not restricted to COPD, and is also a significant feature of other obstructive airway diseases such as bronchiectasis, (Simpson et al., 2007) allergic bronchopulmonary aspergillosis (ABPA), (Wark et al., 2000) and the neutrophilic asthma sub-type. (Simpson et al., 2006) The mechanisms which underpin the development of airway neutrophilia appear to be similar and remarkably consistent across these different obstructive airway diseases. The induction of neutrophilic bronchitis involves upregulated gene expression and protein secretion of the potent neutrophil chemoattractant CXCL8 (Fig. 2) (Simpson et al., 2007), as well as release of neutrophil proteases. This commonality of features suggests similar mechanisms may be operating to potentiate neutrophilic bronchitis in the various obstructive airway diseases, and also that similar therapeutic approaches may be beneficial in this diverse range of airway diseases. This review will examine these issues and the mechanisms and potential therapy of neutrophilic bronchitis across different obstructive airway diseases.
Section snippets
Burden of illness from obstructive airways diseases
The diseases that are associated with airflow obstruction include asthma, COPD, bronchiectasis as well as less common conditions such as diffuse panbronchiolitis, bronchiolitis associated with connective tissue diseases, and obliterative bronchiolitis associated with transplantation (Table 1). Interestingly, a neutrophilic bronchitis (Fig. 1) can characterise most of these diseases. Asthma and COPD are the most common obstructive airway diseases with each affecting approximately 10% of the
Neutrophilic bronchitis in obstructive airways disease
Airway inflammation is recognised as a key underlying pathophysiological process in asthma, COPD and bronchiectasis. The inflammatory response in asthma is heterogeneous, with noneosinophilic forms of the disease increasingly recognised. Noneosinophilic asthma can exhibit a neutrophilic pattern, or a pattern with normal levels of airway granulocytes, termed paucigranulocytic asthma.(Simpson et al., 2006) Characterisation of inflammatory subtypes of asthma is useful in determining treatment and
Mechanisms linking neutrophilic bronchitis across obstructive airways diseases
Patients with neutrophilic asthma, COPD, bronchiectasis and ABPA are all characterized by an increased number of airway inflammatory cells (increased total cell count) and an increased proportion of neutrophils in sputum. One of the key mediators involved in neutrophil influx into the lung is the chemokine CXCL8. When compared to healthy people, there are increased levels of CXCL8 in each of these conditions, with increases in both CXCL8 protein and gene expression for CXCL8 (Wark et al., 2000,
Neutrophil Activation Cycle
We propose the existence of an active amplification mechanism operating in persistent neutrophilic bronchitis across different airway diseases. This involves positive feedback interactions between CXCL8, neutrophils, and the released neutrophil proteases, NE and MMP-9 (Fig. 3).
The biological mechanisms responsible for this positive feedback cycle in neutrophilic bronchitis have been well characterised using in vitro systems. When cultured neutrophils are treated with CXCL8, MMP-9 is rapidly
Mechanisms of neutrophil persistence
Removal of neutrophils from the airways involves pre-programmed apoptosis and is generally followed by phagocytosis of apoptotic cells by macrophages (termed efferocytosis) resulting in the resolution of neutrophilic inflammation. Impairment in either of these processes may lead to secondary necrosis of neutrophils and release of proteolytic enzymes (NE and MMP-9) as well as neutrophil chemoattractants (CXCL8). Perpetuation of the Neutrophil Activation Cycle through either impaired apoptosis or
The innate immune response and neutrophilic bronchitis
The Neutrophil Activation Cycle that typifies persistent neutrophilic bronchitis (Fig. 3) represents an effector arm of the innate immune response. In OAD, the effectors responsible for triggering this cycle remain unknown. It is known however; that toll like receptor (TLR)s have a well established ‘sensing’ and signalling role in the initiation of innate immune responses. TLRs are germ-line encoded receptors that recognise specific pathogen associated molecular patterns. Pathogen associated
The role of TLR2 in the Neutrophil Activation Cycle
TLR2 expression can be upregulated by a variety of stimuli including bacterial products (such as LPS, heat shock proteins, lipoteichoic acid and peptidoglycan), pro-inflammatory cytokines and corticosteroids. (Shuto et al., 2002, Hayashi et al., 2003, Hermoso et al., 2004, Sakai et al., 2004) Corticosteroids are the mainstay treatment of asthma and are used widely in COPD. The influence of corticosteroids on the upregulation of the innate immune response, in particular of TLR2 activation,
Macrolides
The anti-inflammatory effects of macrolide antibiotics are well-established. Macrolide antibiotics such as azithromycin have separate and distinct antibiotic and anti-inflammatory actions. As antibacterial agents, macrolides have been widely used in the treatment of infections caused by atypical bacteria such as Chlamydia pneumoniae and Mycoplasma pneumoniae which are associated with OAD. Macrolide antibiotics have become first line therapy in diffuse panbronchiolitis and many reports are now
Future directions
This review indicates several future research directions. The role of TLR2 in airways disease requires further elucidation, primarily in studies of different groups of patients with airways disease, and before and after disease exacerbation. There are opportunities to test the clinical efficacy of some of the treatments highlighted here, as well as to identify treatments that improve neutrophil removal, reduce neutrophil necrosis and reduce innate immune response. A critical question is to
Conclusions
Persistent neutrophilic bronchitis is a common feature of a variety of obstructive airways diseases. The presence of persistent neutrophilic inflammation results in excessive release of damaging neutrophil proteases NE and MMP-9 as well as the chemoattractant CXCL8. Little is understood about the inflammatory processes which lead to the persistence and activation of neutrophils in the airways but impairment of efferocytosis and mucus hypersecretion may be involved, processes which are further
References (128)
- et al.
Effect of inhaled endotoxin on airway and circulating inflammatory cell phagocytosis and CD11b expression in atopic asthmatic subjects
J Allergy Clin Immunol
(2003) - et al.
Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma
Ann Allergy Asthma Immunol
(2000) Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogenous disease
Lancet
(2008)- et al.
Chronic exposure to TNF-alpha increases airway mucus gene expression in vivo
J Allergy Clin Immunol
(2005) - et al.
Smoking and airway inflammation in patients with mild asthma
Chest
(2001) - et al.
CXCR2 antagonists for the treatment of pulmonary disease
Pharmacol Ther
(2009) - et al.
Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop
J Biol Chem
(2003) - et al.
Toll-like receptor 2 expression on human conjunctival eptithelial cells: a pathway for Staphylococcus aureus involvement in chronic ocular proinflammatory responses
Ann Allergy Asthma Immunol
(2005) - et al.
Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma
Respir Med
(2005) - et al.
Structural complementarity of toll/interleukin-1 receptor domains in toll-like receptors and the adaptors mal and myd88
J Biol Chem
(2003)
Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failure
Int J Cardiol
Migratory responses of eosinophil and neutrophil granulocytes from patients with asthma
J Allergy Clin Immunol
Toll-like receptors stimulate human neutrophil function
Blood
Long-term treatment with theophylline reduces neutrophils, interleukin-8 and tumor necrosis factor-alpha in the sputum of patients with chronic obstructive pulmonary disease
Pulm Pharmacol Ther
Epithelial mucin stores are increased in the large airways of smokers with airflow obstruction
Chest
Mechanisms of mucin production by rhinovirus infection in cultured human epithelial cells
Respir Physiol Neurobiol
Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (Progelatinase B) by human neutrophil elastase
J Biol Chem
Signaling to nf-kappab by toll-like receptors
Trends Mol Med
Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model
Eur J Pharmacol
A comparison of airway and serum matrix metalloproteinase-9 activity among normal subjects, asthmatic patients, and patients with asthmatic mucus hypersecretion
Chest
The relation between peripheral blood leukocyte counts and respiratory symptoms, atopy, lung function, and airway responsiveness in adults
Chest
Aggregrates of ultrafine particles impair phagocytosis of microorganisms by human alveolar macrophages
Environ Res
Efficacy and safety of a monoclonal antibody recognizing interleukin-8 in COPD
Chest
Murine TLR2 expression analysis and systemic antagonism by usage of specific monoclonal antibodies
Immunol Lett
Simvastatin does not exhibit therapeutic anti-inflammatory effects in asthma
J Allergy Clin Immunol
The neutrophil in chronic obstructive pulmonary disease
J Allergy Clin Immunol
Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium
Am J Respir Cell Mol Biol
Bronchial inflammation and colonization in patients with clinical stable bronchiectasis
Am J Respir Crit Care Med
Globlet cell degranulation after antigen challenge in sensitized guinea pigs. Role of neutrophils
Am J Respir Crit Care Med
Myd88-dependent and myd88-independent pathways in synergy, priming, and tolerance between tlr agonists
J Immunol
Cigarette smoke synergistically enhances respiratory mucing induction by proinflammatory stimuli
Am J Respir Cell Mol Biol
Increased bronchoalveolar granulocytes and granulocyte/macrophage colony-stimulating factor during exacerbations of chronic bronch
Eur Respir J
The effect of oral clarithromycin on health status and sputum bacteriology in stable COPD
Respir Med
Impaired phagoctyosis of nontypeable Haeomphilus influenzae by human alveolar macrophages in COPD
J Infect Dis
Evidence of a role of tumor necrosis factor α in refractory asthma
N Engl J Med
Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study
Int J Clin Prac
Toll like receptor-2 modulates both innate and adaptive immune responses during chronic fungal asthma in mice
Inflamm Res
Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma
Thorax
Bronchiectasis in indigenous children in remote Australian communities
Med J Aust
Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma
Am J Respir Crit Care Med
Glucocorticoid treatment inhibits apoptosis in human neutrophils
J Immunol
Effect of theophylline on induced sputum inflammatory indices and neutrophil chemotaxis in chronic obstructive pulmonary disease
Am J Respir Crit Care Med
Mucociliary clearance in patients with chronic asthma: effects of beta agonists
Respirology
The effects of a monoclonal antibody directed against tumor necrosis fractor-alpha in asthma
Am J Respir Crit Care Med
Mucus hypersecretion in bronchiectasis the role of neutrophil protease
Am Rev Respir Dis
Alveolar macrohpage phagocytosis is imparied in children with poorly controlled asthma
J Allergy Clin Immunol
Collaborative induction of inflammatory responses by dectin-1 and toll-like receptor 2
J Exp Med
Induced sputum IL-8 gene expression, neutrophil influx and MMP-9 in allergic bronchopulmonary aspergillosis
Eur Resp J
Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids
Thorax
alpha-1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients
Eur Respir J
Cited by (70)
Dendrobium officinale polysaccharides ameliorated pulmonary function while inhibiting mucin-5AC and stimulating aquaporin-expression
2016, Journal of Functional FoodsCitation Excerpt :Therefore, functional foods and diet therapy may be promising alternatives for the treatment of COPD. COPD is characterised by chronic inflammation, progressive and irreversible airflow limitation with long-term cigarette smoking stimulated chronic pulmonary inflammation as its most accepted pathogenesis (Decramer, Janssens, & Miravitlles, 2002; Kubo et al., 2005; Simpson, Phipps, & Gibson, 2009). Cigarette smoke (CS) induced chronic pulmonary inflammatory processes ultimately lead to small airway obstruction and reduction of mucosal ciliary motility, goblet cell number increment, and mucus hypersecretion (Lee, Taneja, & Vassallo, 2012; Yang et al., 2006).
Chronic obstructive pulmonary diseases in children
2015, Jornal de PediatriaMicroRNA-9 regulates steroid-resistant airway hyperresponsiveness by reducing protein phosphatase 2A activity
2015, Journal of Allergy and Clinical ImmunologyIL-27 Levels in Bronchoalveolar Lavage Fluid in Children with Post-infectious Bronchiolitis Obliterans
2024, Iranian Journal of Immunology